F. M. Nagengast

Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis

JT Wijnen, FH Menko, JH Kleibeuker et al. · Gastroenterology · 1996 · 824 citations · Full text

Life Sciences, Genetics, Oncology +16

Cost effectiveness of a new strategy to identify HNPCC patients

Wietske Kievit, J H F M de Bruin, E. M. Adang et al. · Gut · 2004 · 90 citations · Full text

Medicine, Oncology, Pathology +17

Evaluation of seven tumor markers (CA 50, CA 19-9, CA 19-9 TruQuant, CA 72-4, CA 195, carcinoembryonic antigen, and tissue polypeptide antigen) in the pretreatment sera of patients with gastric carcinoma

Theo Wobbes, Chris M.G. Thomas, M F Segers et al. · Cancer · 1992 · 58 citations · Full text

Medicine, Oncology, Pathology +17

Epidermal growth factor receptor levels are lower in carcinomatous than in normal colorectal tissue

WHM Peters, Th. Wobbes, L.V.A.M. Beex et al. · British Journal of Cancer · 1992 · 41 citations

Medicine, Cancer Biology, Oncology +12

Plasminogen activators and inhibitor type 1 in neoplastic colonic tissue from patients with familial adenomatous polyposis

G Griffioen, S Ganesh, F. M. Nagengast et al. · British Journal of Cancer · 1995 · 22 citations · Full text

Medicine, Oncology, Pathology +17